Scarica l'app Stockscreener
7.65
1.67%
-0.13
Dopo l'orario di chiusura:
7.65
Biocryst Pharmaceuticals Inc Azioni (BCRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
39.53%
218.25
|
156.41 | 406.56 | 159.40 | 163.35 |
| Cost Of Revenue |
28.58%
3.84
|
5.377 | 9.522 | 2.187 | 2.798 |
Selling, General, and Administrative
|
32.34%
63.98
|
94.55 | - | - | - |
| Costs And Expenses |
86.04%
119.78
|
858.01 | 146.17 | 129.80 | 133.57 |
| Operating Income/Loss |
114.03%
98.47
|
-701.60 | 260.38 | 29.59 | 29.79 |
| Nonoperating Income/Loss |
1.14%
-18.99
|
-19.21 | -12.37 | -17.46 | -23.30 |
| Income/Loss From Continuing Operations Before Tax |
111.03%
79.47
|
-720.81 | 248.02 | 12.13 | 6.486 |
| Income Tax Expense/Benefit |
7.47%
1.079
|
1.004 | 2.172 | -0.769 | 1.401 |
| Net Income/Loss |
110.86%
78.39
|
-721.81 | 245.84 | 12.90 | 5.085 |
| Basic Average Shares |
5.05%
254.48
|
242.26 | 0.362 | 210.18 | 209.52 |
| Diluted Average Shares |
9.46%
265.17
|
242.26 | 0.232 | 219.88 | 219.89 |
| Basic Earnings Per Share |
110.40%
0.31
|
-2.98 | 1.17 | 0.06 | 0.02 |
| Diluted Earnings Per Share |
110.07%
0.30
|
-2.98 | 1.13 | 0.06 | 0.02 |
4.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):